202468-47-1
Chemical Structure
L-Methionine-13C5,15N
- CAS No.: 202468-47-1
- Formula:13C5H1115NO2S
- Molecular Weight:155.17
IUPAC Name: L-methionine-13C5-15N
InChIKey: FFEARJCKVFRZRR-XAFSXMPTSA-N
SMILES: O[13C]([13C@@H]([15NH2])[13CH2][13CH2]S[13CH3])=O
Biological Activity: L-Methionine-13C5,15N is the 13C- and 15N-labeled L-Methionine. L-Methionine is the L-isomer of Methionine, an essential amino acid for human development. Methionine acts as a hepatoprotectant.
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
L-Methionine-13C5,15N | 99.62% | L-Methionine-13C5,15N is the 13C- and 15N-labeled L-Methionine. L-Methionine is the L-isomer of Methionine, an essential amino acid for human development. Methionine acts as a hepatoprotectant. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Methionine (Standard) | 99.95% | L-Methionine (Standard) is the analytical standard of L-Methionine. This product is intended for research and analytical applications. L-Methionine is an L-isomer of orally active Methionine, an essential amino acid. Methionine is a strong liver antidote that acts as a liver protector. L-Methionine can inhibit cell proliferation and induce cell apoptosis. L-Methionine has antitumor and antioxidant activity. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Methionine-13C,d5 | 98% | L-Methionine-13C,d5 is the 13C- and deuterium labeled L-Methionine. L-Methionine is the L-isomer of Methionine, an essential amino acid for human development. Methionine acts as a hepatoprotectant. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Methionine-d4 | 99.92% | L-Methionine-d4 is the deuterium labeled L-Methionine. L-Methionine is the L-isomer of Methionine, an essential amino acid for human development. Methionine acts as a hepatoprotectant. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Methionine-13C | 99.93% | L-Methionine-13C is the 13C-labeled L-Methionine. L-Methionine is the L-isomer of Methionine, an essential amino acid for human development. Methionine acts as a hepatoprotectant. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Methionine-1-13C | 98.0% | L-Methionine-1-13C is the 13C-labeled L-Methionine. L-Methionine is the L-isomer of Methionine, an essential amino acid for human development. Methionine acts as a hepatoprotectant. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Methionine-34S | 99.89% | L-Methionine-34S is a 34S-labeled L-Methionine. L-Methionine is the L-isomer of Methionine, an essential amino acid for human development. Methionine acts as a hepatoprotectant. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Methionine-d3 | 99.92% | L-Methionine-d3 is the deuterium labeled L-Methionine. L-Methionine is the L-isomer of Methionine, an essential amino acid for human development. Methionine acts as a hepatoprotectant. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Methionine-13C,d3 | 99.9% | L-Methionine-13C,d3 is the 13C- and deuterium labeled L-Methionine. L-Methionine is the L-isomer of Methionine, an essential amino acid for human development. Methionine acts as a hepatoprotectant. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Methionine-d8 | 98.0% | L-Methionine-d8 is the deuterium labeled L-Methionine. L-Methionine is the L-isomer of Methionine, an essential amino acid for human development. Methionine acts as a hepatoprotectant. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Methionine-d1 | L-Methionine-d1 is the deuterium labeled L-Methionine (HY-N0326). L-Methionine is an L-isomer of orally active Methionine, an essential amino acid. Methionine is a strong liver antidote that acts as a liver protector. L-Methionine can inhibit cell proliferation and induce cell apoptosis. L-Methionine has antitumor and antioxidant activity. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Methionine-15N | 99.50% | L-Methionine-15N is the 15N-labeled L-Methionine. L-Methionine is the L-isomer of Methionine, an essential amino acid for human development. Methionine acts as a hepatoprotectant. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Methionine-15N,d8 | L-Methionine-15N,d8 is the deuterium and 15N-labeled L-Methionine. L-Methionine is the L-isomer of Methionine, an essential amino acid for human development. Methionine acts as a hepatoprotectant. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Methionine-13C5 | 99.96% | L-Methionine-13C5 is the 13C-labeled L-Methionine. L-Methionine is the L-isomer of Methionine, an essential amino acid for human development. Methionine acts as a hepatoprotectant. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Methionine | 99.98% | L-Methionine is an L-isomer of orally active Methionine, an essential amino acid. Methionine is a strong liver antidote that acts as a liver protector. L-Methionine can inhibit cell proliferation and induce cell apoptosis. L-Methionine has antitumor and antioxidant activity. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
D-Glutamic acid-d5 | 99.91% | D-Glutamic acid-d5 is the deuterium labeled D-Glutamic acid. D-glutamic acid, an enantiomer of L- glutamic acid, is widely used in pharmaceuticals and foods. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Methionine | 99.92% | Methionine (MRX-1024; D-Methionine) is an effective chemoprotective agent which can also inhibit the neuronal activity through GABAA receptor activation. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Methionine (Standard) | ≥98% | Methionine (Standard) is the analytical standard of Methionine. This product is intended for research and analytical applications. Methionine (MRX-1024; D-Methionine) is an effective chemoprotective agent which can also inhibit the neuronal activity through GABAA receptor activation. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Methionine-d3 | 99.22% | Methionine-d3 is the deuterium labeled Methionine. Methionine (MRX-1024; D-Methionine) is an effective chemoprotective agent which can also inhibit the neuronal activity through GABAA receptor activation. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Glutamic acid-13C5,15N,d5 | 99.0% | L-Glutamic acid-13C5,15N,d5 is the deuterium, 13C-, and 15-labeled L-Glutamic acid. L-Glutamic acid acts as an excitatory transmitter and an agonist at all subtypes of glutamate receptors (metabotropic, kainate, NMDA, and AMPA). L-Glutamic acid shows a direct activating effect on the release of DA from dopaminergic terminals. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Glutamic acid-d5 | 99.84% | L-Glutamic acid-d5 is the deuterium labeled L-Glutamic acid. L-Glutamic acid acts as an excitatory transmitter and an agonist at all subtypes of glutamate receptors (metabotropic, kainate, NMDA, and AMPA). L-Glutamic acid shows a direct activating effect on the release of DA from dopaminergic terminals. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
D-Norvaline | 98.94% | D-Norvaline is a valine derivative. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
D-Alanine-d3 | 99.83% | D-Alanine-d3 is the deuterium labeled D-Alanine. D-Alanine is a weak GlyR (inhibitory glycine receptor) and PMBA agonist, with an EC50 of 9 mM for GlyR. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Penicillamine-d3 | Penicillamine-d3 is the deuterium labeled Penicillamine. Penicillamine (D-(-)-Penicillamine) is the most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
(±)-Leucine-d10 | 98.0% | (±)-Leucine-d10 is the deuterium labeled (±)-Leucine. (±)-Leucine (DL-Leucine), an isomer of Leucine, chemosterilant and dietary additive. (±)-Leucine inhibits growth of Escherichia coli HfrH by 92.08%. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
S-Methyl-L-cysteine | 99.96% | S-Methyl-L-cysteine is a natural product that acts as a substrate in the catalytic antioxidant system mediated by methionine sulfoxide reductase A (MSRA), with antioxidative, neuroprotective, and anti-obesity activities. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
S-Methyl-L-cysteine (Standard) | 99.12% | S-Methyl-L-cysteine (Standard) is the analytical standard of S-Methyl-L-cysteine. This product is intended for research and analytical applications. S-Methyl-L-cysteine is a natural product that acts as a substrate in the catalytic antioxidant system mediated by methionine sulfoxide reductase A (MSRA), with antioxidative, neuroprotective, and anti-obesity activities. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Alloisoleucine-d10 | L-Alloisoleucine-d10 is the deuterium labeled L-Alloisoleucine. L-Alloisoleucine is a branched chain amino acid and is a stereo-isomer of L-isoleucine. L-Alloisoleucine is a common constituent of human plasma (albeit at low levels). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Valine-d8 | 99.91% | L-Valine-d8 is a deuterated form of L-Valine (HY-N0717). L-Valine ((S)-Valine) is a nonlinear semiorganic material. L-Valine causes lipid peroxidation and accumulation of malondialdehyde (MDA), exhibits inhibitory activity against cyanobacteria. L-Valine inhibits multidrug-resistant bacteria through activation of PI3K/Akt signaling pathway and inhibition of arginase. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
DL-Methionine | 98.0% | DL-Methionine is an essential amino acid containing sulfur with oxidative stress defense effects. DL-Methionine can be used for animal natural feed. DL-Methionine also kills H. rostochiensis on potato plants. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
DL-Methionine (Standard) | ≥98% | DL-Methionine (Standard) is the analytical standard of DL-Methionine. This product is intended for research and analytical applications. DL-Methionine is an essential amino acid containing sulfur with oxidative stress defense effects. DL-Methionine can be used for animal natural feed. DL-Methionine also kills H. rostochiensis on potato plants. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
DL-Methionine-13C | DL-Methionine-13C is the 13C-labeled DL-Methionine. DL-Methionine is an essential amino acid containing sulfur with oxidative stress defense effects. DL-Methionine can be used for animal natural feed. DL-Methionine also kills H. rostochiensis on potato plants. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
DL-Methionine-d3 | DL-Methionine-d3 is the deuterium labeled DL-Methionine. DL-Methionine is an essential amino acid containing sulfur with oxidative stress defense effects. DL-Methionine can be used for animal natural feed. DL-Methionine also kills H. rostochiensis on potato plants. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
DL-Methionine-d4 | 99.89% | DL-Methionine-d4 is the deuterium labeled DL-Methionine. DL-Methionine is an essential amino acid containing sulfur with oxidative stress defense effects. DL-Methionine can be used for animal natural feed. DL-Methionine also kills H. rostochiensis on potato plants. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Leucine-d10 | 99.0% | L-Leucine-d10 is the deuterium labeled L-Leucine. L-Leucine is an essential branched-chain amino acid (BCAA), which activates the mTOR signaling pathway. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Leucine-d3 | 99.98% | L-Leucine-d3 is the deuterium labeled L-Leucine. L-Leucine is an essential branched-chain amino acid (BCAA), which activates the mTOR signaling pathway. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
D-Valine-d8 | 99.09% | D-Valine-d8 is the deuterium labeled D-Valine. D-Valine is the enantiomer of L-Valine (HY-N0717). L-Valine is one of 20 proteinogenic amino acids. L-Valine is an essential amino acid. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Valine-13C5,15N,d8 | L-Valine-13C5,15N,d8 ((S)-Valine-13C5,15N,d8) is the deuterium, 13C-, and 15N-labeled L-Valine (HY-N0717). L-Valine ((S)-Valine) is a nonlinear semiorganic material. L-Valine causes lipid peroxidation and accumulation of malondialdehyde (MDA), exhibits inhibitory activity against cyanobacteria. L-Valine inhibits multidrug-resistant bacteria through activation of PI3K/Akt signaling pathway and inhibition of arginase. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Isoleucine-13C6,15N,d10 | 99.9% | L-Isoleucine-13C6,15N,d10 is the deuterium, 13C-, and 15-labeled L-Isoleucine. L-isoleucine is a nonpolar hydrophobic amino acid. L-Isoleucine is an essential amino acid. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
DL-Cystathionine-d4 | 99.20% | DL-Cystathionine-d4 is the deuterium labeled DL-Cystathionine (HY-W009749A). DL-Cystathionine is a mixture of 4 isomers of cystathionine and allocystathionine. DL-Cystathionine also is an intermediate in the biosynthesis of amino acid cysteine. DL-Cystathionine serves as a standard for quantifying tissue cystathionine. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
DL-Homocysteine-d4 | 99.70% | DL-Homocysteine-d4 is the deuterium labeled DL-Homocysteine. DL-Homocysteine is a weak neurotoxin, and can affect the production of kynurenic acid in the brain. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
DL-Norvaline (Standard) | ≥98% | DL-Norvaline (Standard) is the analytical standard of DL-Norvaline. This product is intended for research and analytical applications. DL-Norvaline, a derivative of L-norvaline, L-norvaline is a non-competitive inhibitor of arginase. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-2-Aminobutyric acid-d3 | L-2-Aminobutyric acid-d3 is the deuterium labeled L-2-Aminobutyric acid. L-2-Aminobutyric acid is a non-proteinogenic amino acid that exists in human tissues and body fluids. L-2-Aminobutyric acid is formed by the transamination of oxobutyric acid. L-2-Aminobutyric acid can serve as a precursor for anticonvulsant and anti-tuberculosis agents and is a key intermediate in the chemical and pharmaceutical industries. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-2-Aminobutyric acid-d6 | 99.92% | L-2-Aminobutyric acid-d6 is the deuterium labeled L-2-Aminobutyric acid. L-2-Aminobutyric acid is a non-proteinogenic amino acid that exists in human tissues and body fluids. L-2-Aminobutyric acid is formed by the transamination of oxobutyric acid. L-2-Aminobutyric acid can serve as a precursor for anticonvulsant and anti-tuberculosis agents and is a key intermediate in the chemical and pharmaceutical industries. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
(Rac)-2-Aminobutyric acid-d3 | (Rac)-2-Aminobutyric acid-d3 is the deuterium labeled (Rac)-2-Aminobutyric acid. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
H-DL-Abu-OH-d6 | 99.98% | H-DL-Abu-OH-d6 is the deuterium labeled H-DL-Abu-OH. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
DL-Valine-d8 | 99.96% | DL-Valine-d8 is the deuterium labeled DL-Valine. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
2-Amino-4-sulfobutanoic acid-d4 | 2-Amino-4-sulfobutanoic acid-d4 is the deuterium labeled 2-Amino-4-sulfobutanoic acid. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Ornithine-d6 hydrochloride | 99.92% | L-Ornithine-d6 hydrochloride is the d6-labeled L-Ornithine hydrochloride (HY-W017018). L-Ornithine hydrochloride is an orally active CaSR and p38 activator. L-Ornithine hydrochloride inhibits ROS and supports urea cycle function. L-Ornithine hydrochloride can be used to study kidney diseases involving proximal tubular cell damage caused by oxidative stress or crystallopathy, as well as research related to anxiety disorders. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Ornithine-d2 hydrochloride | 99.94% | L-Ornithine-d2 hydrochloride is the d2-labeled L-Ornithine hydrochloride (HY-W017018). L-Ornithine hydrochloride is an orally active CaSR and p38 activator. L-Ornithine hydrochloride inhibits ROS and supports urea cycle function. L-Ornithine hydrochloride can be used to study kidney diseases involving proximal tubular cell damage caused by oxidative stress or crystallopathy, as well as research related to anxiety disorders. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Ethionine | 99.66% | L-Ethionine (L-ETH) is an amino acid derivative. L-Ethionine serves as a substrate for ATP:L-methionine S-adenosyltransferase, which targets its L-stereoisomer. L-Ethionine blocks the synthesis of N6-dimethyladenosine in rat liver tRNA/4S RNA via its major hepatic metabolite S-adenosylethionine, inducing methyl-deficient rat liver tRNA/4S RNA. L-Ethionine can be used in studies of liver cancer and hepatocarcinogenesis mechanisms. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
2-Amino-4-(ethylthio)butanoic acid | 99.36% | 2-Amino-4-(ethylthio)butanoic acid is a Methionine (HY-13694) derivative. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
DL-Glutamic acid-d5 | 99.89% | DL-Glutamic acid-d5 is the deuterium labeled DL-Glutamic acid. DL-Glutamic acid is the conjugate acid of Glutamic acid, which acts as a fundamental metabolite. Comparing with the second phase of polymorphs α and β L-Glutamic acid, DL-Glutamic acid presents better stability. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Homocysteine-d4 | 98.78% | L-Homocysteine-d4 is deuterium labeled L-Homocysteine (HY-W010347). L-Homocysteine, an amino acid, is a homocysteine that has L configuration. Homocysteine is an essential intermediate in normal mammalian metabolism of methionine. L-Homocysteine induces upregulation of Cathepsin V that mediates vascular endothelial inflammation in hyperhomocysteinaemia | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
2-Aminobutanoic-4,4,4 acid hydrochloride-d3 | 2-Aminobutanoic-4,4,4 acid hydrochloride-d3 is the deuterium labeled 2-Aminobutanoic-4,4,4 acid hydrochloride. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
D(-)-2-Aminobutyric acid-d6 | D(-)-2-Aminobutyric acid-d6 is the deuterium labeled D(-)-2-Aminobutyric acid. D(-)-2-Aminobutyric acid is a substrate of D-amino acid oxidase. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
D-Leucine-d10 | 99.96% | D-Leucine-d10 is the deuterium labeled D-Leucine. D-Leucine is a more potent anti-seizure agent than L-leucine. D-leucine potently terminates seizures even after the onset of seizure activity. D-leucine, but not L-leucine, reduces long-term potentiation but had no effect on basal synaptic transmission in vitro. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Norvaline (Standard) | ≥98% | L-Norvaline (Standard) is the analytical standard of L-Norvaline (HY-Y0399). This product is intended for research and analytical applications. L-Norvaline is the inhibitor for arginase, that promotes the production of NO, reduces oxidative stress, improves insulin resistance, and exhibits antioxidant and anti-hyperglycemic effects. L-Norvaline can be used in research of Alzheimer’s disease. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Norvaline-d5 | 99.9% | L-Norvaline-d5 is the deuterium labeled L-Norvaline. L-Norvaline is the inhibitor for arginase, that promotes the production of NO, reduces oxidative stress, improves insulin resistance, and exhibits antioxidant and anti-hyperglycemic effects. L-Norvaline can be used in research of Alzheimer’s disease. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||